Doctor profile · Federal record
Dr. Kathy Vincent, APRN, NP-BC
Nurse Practitioner · Providence, KY
- NPI 1598060899
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
215 E Main St
Providence, KY 424501261
(270) 667-7017
fax (270) 667-9065 - Mailing address
-
Po Box 37
Providence, KY 424500037
Credentials & registration
- NPI registered
- January 2011 — 15 yrs on file
- Profile last updated
- March 2, 2018
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Kentucky #3006796
- Medicaid (2)
- IN #201020300 · KY #7100155800
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1598060899. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,438
Distinct HCPCS
10
Medicare allowed
$191,187
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,299 | 236 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 841 | 518 | $70 | |
17110 |
Destruction of skin growth, 1-14 growths | 560 | 390 | $83 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 426 | 68 | $1 | |
17000 |
Destruction of precancer skin growth, 1 growth | 407 | 286 | $31 | |
11102 |
Biopsy of related skin growth, first growth | 216 | 198 | $53 | |
17111 |
Destruction of skin growth, 15 or more growths | 122 | 89 | $100 | |
11103 |
Biopsy of related skin growth, each additional growth | 119 | 74 | $38 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 93 | 93 | $88 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 87 | 66 | $98 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 261. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$600
Transactions
32
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $260.13 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $62.85 | |
| Krystal Biotech Inc | 2 | $47.73 | |
| ABBVIE INC. | 2 | $46.98 | |
| Janssen Biotech, Inc. | 2 | $36.03 | |
| Organon Llc | 4 | $35.02 | |
| Amgen Inc. | 2 | $34.56 | |
| UCB, Inc. | 1 | $23.58 | |
| Lilly USA, LLC | 1 | $19.56 | |
| Incyte Corporation | 1 | $19.28 | |
| Arcutis Biotherapeutics, Inc. | 1 | $14.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,085
Patients
682
Total drug cost
$35,019
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 196 | 118 | $11,561 |
| Triamcinolone Acetonide | Generic | 165 | 110 | $2,792 |
| Minocycline Hcl | Generic | 101 | 62 | $4,189 |
| Ketoconazole | Generic | 94 | 57 | $1,207 |
| Terbinafine Hcl | Generic | 79 | 33 | $1,116 |
| Fluticasone Propionate | Generic | 59 | 47 | $1,625 |
| Metronidazole | Generic | 59 | 38 | $4,747 |
| Cephalexin | Generic | 55 | 49 | $563 |
| Prednisone | Generic | 46 | 42 | $155 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 42 | 18 | $1,398 |
Frequently asked questions
What is Dr. Kathy Vincent's medical specialty?
Dr. Kathy Vincent practices Nurse Practitioner in Providence, KY.
Where does Dr. Kathy Vincent practice?
Dr. Kathy Vincent practices at 215 E Main St, Providence, KY 424501261. Office phone: 2706677017.
What is Dr. Kathy Vincent's NPI?
Dr. Kathy Vincent's National Provider Identifier (NPI) is 1598060899, issued by NPPES.
Does Dr. Kathy Vincent accept Medicare assignment?
Yes. Dr. Kathy Vincent accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kathy Vincent commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.